Treatments & Management of Vitiligo

Discover evidence-based treatments for vitiligo available in Kenya. Learn about approved therapies, phototherapy, topical treatments, and how to manage the condition effectively. Consult your dermatologist today

Evidence-Based Care for Vitiligo

There is no universal cure for vitiligo, but many effective, scientifically supported options can help stop progression, promote repigmentation, and improve quality of life. At VISOKE, we guide our members toward safe, approved therapies while emphasizing personalized medical advice.

Understanding Treatment Goals

Vitiligo is an autoimmune condition where the body’s immune system attacks melanocytes (pigment-producing cells). Treatment focuses on:

• Stabilizing active disease (stopping new patches).
• Promoting repigmentation (restoring color).
• Improving appearance and self-confidence.
• Protecting skin and addressing emotional well-being.

Results take time (often months) and vary by person. Factors like skin type, age, location of patches, and disease activity influence choices. Always consult a qualified dermatologist for a personalized plan. Important Note: Information on this page is educational and based on current international guidelines and evidence. It is not a substitute for professional medical advice. Treatments available in Kenya may differ from those in other countries due to regulatory approval and access.

First-Line Treatments (Recommended Starting Options) Topical Therapies (creams/ointments applied to the skin)

• Potent or very potent topical corticosteroids — Effective for limited areas, especially in early or active disease.
• Topical calcineurin inhibitors (e.g., tacrolimus 0.1% ointment, pimecrolimus) — Often preferred for face, neck, and sensitive areas; suitable for longer-term use.

Phototherapy

• Narrowband UVB (NB-UVB) — The cornerstone treatment for widespread or progressing vitiligo. Sessions are typically 2–3 times per week at a dermatology clinic. Often combined with topical treatments for better results.

Lifestyle & Supportive Care

• Strict sun protection (broad-spectrum sunscreen SPF 30+, protective clothing) — Essential in Kenya’s climate to prevent sunburn on depigmented skin and reduce contrast.
• Camouflage makeup or self-tanners for cosmetic improvement.
• Psychological support and counseling to address stigma and boost self-esteem.

Advanced & Targeted Therapies Topical JAK Inhibitors

• Ruxolitinib 1.5% cream — A targeted therapy approved for non-segmental vitiligo in people aged 12 and older in several countries. It helps block immune signals that attack pigment cells and has shown good repigmentation results, especially when combined with phototherapy.
  Availability in Kenya:
  Access notes:

Systemic (Oral) Treatments (for active or widespread disease, under specialist supervision)

• Oral mini-pulse corticosteroids or other immunosuppressants — Used short-term to stabilize rapidly progressing vitiligo.

Other oral options under research or specialist care:

Surgical Options (for stable vitiligo – when disease has not progressed for 6–12+ months)

• Skin grafting or melanocyte transplantation techniques — Effective for stable, localized patches, particularly on the face and neck.
• Surgical Options (for stable vitiligo – when disease has not progressed for 6–12+ months)
  Skin grafting or melanocyte transplantation techniques — Effective for stable, localized patches, particularly on the face and neck.
  Treatment Algorithm / Decision Guide
  Limited patches → Topical therapies ± phototherapy
  Widespread / progressing → NB-UVB phototherapy + topicals; consider JAK cream or systemic
  Stable localized → Consider surgical options after medical therapy Recommended Monitoring Tools (used by specialists): VASI score, VIDA score, clinical photos.